Mek162 Side Effects

Report Mek162 Side Effects

If you experienced any harmful or unwanted effects of Mek162, please share your experience. This could help to raise awareness about Mek162 side effects, identify uknown risks and inform health professionals and patients taking Mek162.

Examples: headache, dizziness

The most commonly reported Mek162 side effects are:
Hair Loss (1 reports)

If you have experienced a side effect listed above, you can check a box to report it.

To view a complete list of submitted side effects, please follow the link Mek162 side effects . You can also compare Mek162 side effects or view FDA reports.

Mek162 Side Effects reported to FDA

The following Mek162 reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
The FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

The appearance of Mek162 on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has identified a causal relationship between the drug and the listed risk.

Peritoneal Haemorrhage
on Jan 16, 2014 Female from US , 60 years of age, weighting 126.8 lb, was diagnosed with and was treated with Mek162. Directly after, patient experienced the unwanted or unexpected Mek162 side effects: peritoneal haemorrhage. Mek162 dosage: 30 Mg, Unk.
Associated medications used: Patient was hospitalized.

Nausea, Vomiting, Metastatic Malignant Melanoma, Malignant Neoplasm Progression
Patient was taking Mek162. Patient felt the following Mek162 side effects: nausea, vomiting, metastatic malignant melanoma, malignant neoplasm progression on Nov 18, 2013 from US Additional patient health information: Male , 55 years of age, weighting 154.2 lb, was diagnosed with and. Mek162 dosage: 60 Mg, Unk. Patient was hospitalized.

Adverse event was reported on May 10, 2012 by a Male taking Mek162 (Dosage: Unk) . Location: UNITED STATES , weighting 153.2 lb, After Mek162 was administered, patient encountered several Mek162 side effects: tachycardia.
Multiple concurrent drugs taken:
  • Raf265a (60 Mg, Qd)
  • Sotalol Hcl (Unk)
Patient was hospitalized.

Record and Track Your Side Effects

It is very important to keep track of all side effects and discuss them with your doctor. If you think you may have a medical emergency, call your doctor or 911 immediately.

Track Your Side Effects - It's Easy and Free. >> Start Today

Already a User? Log In

Most drugs have a large list of nonsevere or mild adverse effects which do not rule out continued usage. These effects depend on individual sensitivity, and can include nausea, dizziness, diarrhea, malaise, vomiting, headache, dermatitis, dry mouth, etc. Check commonly reported side effects . These can be considered a form of pseudo-allergic reaction, as not all users experience these effects; many users experience none at all.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Tips for Taking Medicines Properly

Before Taking Mek162

Find Out How to Take Mek162

Discuss Mek162 Side Effects

Did You Have a Mek162 Side Effect?

Yes, Severe
Yes, Moderate
Yes, Minor

How Effective is Mek162 for You?

Exceeded Expectations
Somewhat Effective
Not Effective

Safety Alerts, Active Ingredients, Usage Information

More About Mek162

Side Effects reported to FDA: 3

Mek162 safety alerts: No

Reported deaths: 1

Reported hospitalizations: 3

Latest Mek162 clinical trials

Related health facts